查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613393

数位治疗市场：按组成部分、按应用划分 - 2025-2030 年全球预测

Digital Therapeutics Market by Component (Devices, Software & Services), Application (Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年数位治疗市场估值为64.2亿美元，预计到2024年将达到80.5亿美元，复合年增长率为26.42%，到2030年将达到331.6亿美元。

数位疗法 (DTx) 是指由高品质软体程式提供的实证治疗性介入，用于预防、管理和治疗身体、心理和行为健康状况。之所以需要 DTx，是因为它可以与医疗保健系统整合并提供个人化、可扩展的解决方案，从而改善患者的治疗结果、降低成本并提高可及性。这些解决方案正在应用于多种疾病，特别是糖尿病、肥胖症、心血管疾病、神经系统疾病等慢性疾病，并在医院中具有最终用途，数位应用程式可以无缝整合到患者护理工作流程和诊所居家照护。影响市场的关键成长要素包括慢性病盛行率上升、智慧设备普及率提高、连接性增强以及开始认识到数位疗法是可行的治疗选择的支持性法规结构等。 COVID-19 大流行凸显了对远距患者参与解决方案的需求，创造了利用远端医疗协同效应效应的机会，并扩大了服务不足的人群的覆盖范围，从而增加了 DTx 的潜力。然而，这个市场面临着地区报销结构不同、缺乏标准化以及潜在的监管障碍等限制，为应用带来了挑战。人工智慧驱动的个人化治疗计划、具有更广泛医疗资料系统的整合平台以及增强的用户参与分析等领域将继续创新，以推动更好的依从性和结果。企业应专注于与医疗保健提供者、保险公司和科技公司建立策略伙伴关係关係，以利用跨行业的资源和专业知识。投资大规模临床试验以证明疗效并获得监管部门的核准对于获得信任和接受至关重要。 DTx 市场动态的特点是医疗保健、科技和消费性电子产业的交叉，创造了一个需要创新和灵活回应不断变化的医疗保健需求的动态环境。

主要市场统计
基准年[2023] 64.2亿美元
预计年份 [2024] 80.5亿美元
预测年份 [2030] 331.6亿美元
复合年增长率（%） 26.42%

市场动态：揭示快速发展的数位治疗市场的关键市场洞察

供应和需求的动态相互作用正在改变数位治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病和与生活方式相关的健康问题增加
    • 政府促进远端医疗和远距保健的倡议
    • 与医疗保健应用程式相关的智慧型手机和平板电脑的普及
  • 市场限制因素
    • 新兴经济体对数位疗法的认知较低
  • 市场机会
    • 计算和人工智慧在数位治疗领域的兴起
    • 增加对数位健康业务的资金筹措和投资
  • 市场挑战
    • 资料隐私和安全问题

波特五力：驾驭数位治疗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解数位治疗市场的外部影响

外部宏观环境因素在塑造数位治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解数位治疗市场的竞争格局

对数位治疗市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵数位治疗市场供应商的绩效评估

FPNV定位矩阵是评估数位治疗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製数位治疗市场的成功之路

对于希望加强在全球市场的影响力的公司来说，数位治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病和生活方式相关健康问题的发生率增加
      • 政府推动远端医疗和远距医疗的倡议
      • 结合医疗保健应用程式部署智慧型手机和平板电脑
    • 抑制因素
      • 新兴经济体对数位疗法的认知较低
    • 机会
      • 数位治疗中计算与人工智慧的出现
      • 增加对数位健康业务的资金和投资
    • 任务
      • 资料隐私和安全问题
  • 市场区隔分析
    • 组成部分：资料分析软体和合规服务的重要性日益增加
    • 应用：提高糖尿病和慢性呼吸道疾病数位疗法的采用率，需要持续管理和监控
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章数位治疗市场：按组成部分

  • 装置
  • 软体和服务

第七章数位治疗市场：依应用分类

  • 心血管疾病
  • 中枢神经系统疾病
  • 慢性呼吸道疾病
  • 糖尿病
  • 用药依从性
  • 肌肉骨骼疾病
  • 肥胖
  • 糖尿病前期
  • 禁止抽烟

第八章美洲数位治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太数位治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的数位治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • BehaVR 与 Fern Health 合併成立 RealizedCare，推出数位护理管理平台，释放数位治疗的价值
    • Better Therapeutics 宣布推出 AspyreRxTM 治疗成年第 2 型糖尿病患者
    • Lumanity 加入数位治疗联盟
  • 战略分析和建议

公司名单

  • 2morrow Inc.
  • Akili Interactive Labs, Inc.
  • Ayogo Health Inc.
  • Better Therapeutics, Inc.
  • Big Health, Inc.
  • Biofourmis Inc.
  • Canary Health Technologies Inc.
  • Click Therapeutics, Inc.
  • Cognoa, Inc.
  • DarioHealth Corp.
  • Fern Health, Inc.
  • Fitterfly Healthtech Private Limited
  • Happify, Inc.
  • Headspace Inc.
  • Kaia Health Software Inc.
  • Lark Technologies, Inc.
  • Lumanity Inc.
  • MedRhythms
  • Noom, Inc.
  • Omada Health Inc.
  • Pear Therapeutics, Inc.
  • Propeller Health by ResMed Corp.
  • SilverCloud by American Well Corporation
  • Voluntis by AptarGroup, Inc.
  • Welldoc, Inc.
Product Code: MRR-431752EA4722

The Digital Therapeutics Market was valued at USD 6.42 billion in 2023, expected to reach USD 8.05 billion in 2024, and is projected to grow at a CAGR of 26.42%, to USD 33.16 billion by 2030.

Digital Therapeutics (DTx) refers to evidence-based therapeutic interventions driven by high-quality software programs to prevent, manage, or treat physical, mental, and behavioral health conditions. DTx is necessary due to its ability to integrate with healthcare systems to offer personalized and scalable solutions that contribute to improved patient outcomes, reduced costs, and enhanced accessibility. These solutions have applications across a range of diseases, particularly chronic conditions like diabetes, obesity, cardiovascular diseases, and neurological disorders, and the end-use scope includes hospitals, clinics, and home care settings where digital applications can be seamlessly integrated into patient care workflows. Key growth factors influencing the market include a rising prevalence of chronic diseases, increasing adoption of smart devices, enhanced connectivity, and supportive regulatory frameworks which have begun acknowledging digital therapeutics as viable treatment options. The COVID-19 pandemic highlighted the potential of DTx by underscoring the demand for remote patient engagement solutions, creating opportunities to tap into telehealth synergies, and expanding access to underserved populations. However, the market faces limitations such as varying reimbursement structures, a lack of standardization, and potential regulatory hurdles across different regions, which can pose challenges to widespread adoption. Continued innovations are likely in areas such as AI-driven personalized therapeutic programs, integrative platforms with broader health data systems, and enhanced user engagement analytics that foster better adherence and outcomes. Businesses should focus on forming strategic partnerships with healthcare providers, insurance companies, and technology firms to leverage cross-industry resources and expertise. Investing in extensive clinical trials to demonstrate efficacy and obtaining robust regulatory approvals will be instrumental in gaining trust and acceptance. DTx's market nature, characterized by its intersection with healthcare, technology, and consumer electronics industries, underscores a dynamic environment ripe for innovation and agile responses to evolving healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 6.42 billion
Estimated Year [2024] USD 8.05 billion
Forecast Year [2030] USD 33.16 billion
CAGR (%) 26.42%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Therapeutics Market

The Digital Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of chronic diseases and lifestyle-related health issues
    • Government initiatives promoting telehealth and telemedicine
    • Adoption of smartphones and tablets coupled with healthcare apps
  • Market Restraints
    • Limited awareness regarding digital therapeutics in developing economies
  • Market Opportunities
    • Advent of computing and artificial intelligence in digital therapeutics
    • Rising funding and investments for digital health businesses
  • Market Challenges
    • Issues pertaining to data privacy and security

Porter's Five Forces: A Strategic Tool for Navigating the Digital Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Therapeutics Market

A detailed market share analysis in the Digital Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Therapeutics Market

A strategic analysis of the Digital Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Therapeutics Market, highlighting leading vendors and their innovative profiles. These include 2morrow Inc., Akili Interactive Labs, Inc., Ayogo Health Inc., Better Therapeutics, Inc., Big Health, Inc., Biofourmis Inc., Canary Health Technologies Inc., Click Therapeutics, Inc., Cognoa, Inc., DarioHealth Corp., Fern Health, Inc., Fitterfly Healthtech Private Limited, Happify, Inc., Headspace Inc., Kaia Health Software Inc., Lark Technologies, Inc., Lumanity Inc., MedRhythms, Noom, Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health by ResMed Corp., SilverCloud by American Well Corporation, Voluntis by AptarGroup, Inc., and Welldoc, Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Devices and Software & Services.
  • Based on Application, market is studied across Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease, Diabetes, Medication Adherence, Musculoskeletal Disorder, Obesity, Prediabetes, and Smoking Cessation.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of chronic diseases and lifestyle-related health issues
      • 5.1.1.2. Government initiatives promoting telehealth and telemedicine
      • 5.1.1.3. Adoption of smartphones and tablets coupled with healthcare apps
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness regarding digital therapeutics in developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advent of computing and artificial intelligence in digital therapeutics
      • 5.1.3.2. Rising funding and investments for digital health businesses
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to data privacy and security
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Growing significance of data analysis software and compliance services
    • 5.2.2. Application: Higher adoption of digital therapeutics in diabetes and chronic respiratory diseases, requiring continuous management and monitoring
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Therapeutics Market, by Component

  • 6.1. Introduction
  • 6.2. Devices
  • 6.3. Software & Services

7. Digital Therapeutics Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Central Nervous System Disorder
  • 7.4. Chronic Respiratory Disease
  • 7.5. Diabetes
  • 7.6. Medication Adherence
  • 7.7. Musculoskeletal Disorder
  • 7.8. Obesity
  • 7.9. Prediabetes
  • 7.10. Smoking Cessation

8. Americas Digital Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Digital Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Digital Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics
    • 11.3.2. Better Therapeutics Announces Launch of AspyreRxTM to Treat Adults with Type 2 Diabetes
    • 11.3.3. Lumanity Joins The Digital Therapeutics Alliance
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 2morrow Inc.
  • 2. Akili Interactive Labs, Inc.
  • 3. Ayogo Health Inc.
  • 4. Better Therapeutics, Inc.
  • 5. Big Health, Inc.
  • 6. Biofourmis Inc.
  • 7. Canary Health Technologies Inc.
  • 8. Click Therapeutics, Inc.
  • 9. Cognoa, Inc.
  • 10. DarioHealth Corp.
  • 11. Fern Health, Inc.
  • 12. Fitterfly Healthtech Private Limited
  • 13. Happify, Inc.
  • 14. Headspace Inc.
  • 15. Kaia Health Software Inc.
  • 16. Lark Technologies, Inc.
  • 17. Lumanity Inc.
  • 18. MedRhythms
  • 19. Noom, Inc.
  • 20. Omada Health Inc.
  • 21. Pear Therapeutics, Inc.
  • 22. Propeller Health by ResMed Corp.
  • 23. SilverCloud by American Well Corporation
  • 24. Voluntis by AptarGroup, Inc.
  • 25. Welldoc, Inc.

LIST OF FIGURES

  • FIGURE 1. DIGITAL THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023